The early results of a trial of an experimental drug left White House officials hopeful. President Trump is pressing a crash vaccine program, but experts see risk in a rushed process.
from Health https://ift.tt/2zC5BrK
April 30, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Future Vaccines Depend on Test Subjects in Short Supply: MonkeysThe pandemic has highlighted the United States’ dependence on China for research animals, reviving calls for a “strategic monkey reserve.” from NYT > Health https://ift.tt/3aLWcy1 … Read More
How Meaningful Is Prediabetes for Older Adults?A new study indicates that the condition might be less of a worry than once believed. from NYT > Health https://ift.tt/2NS38Ri … Read More
Researchers Halt Trial of Promising Sickle Cell TreatmentTwo patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible. from NYT > Health https://ift.tt/3kdQBna … Read More
U.S. Reaches 500,000 Covid DeathsIn a single year, Covid-19 became a leading cause of death in the United States, rivaling heart disease and cancer, and has driven life expectancy down sharply. from NYT > Health https://ift.tt/37GfHGh … Read More
Where a Vaccination Campaign Faces Skepticism, War and CorruptionA half-million doses arrived this month in Afghanistan, where many insist the virus isn’t real and vaccines aren’t needed. Those who want the vaccine fear that only the well-connected will receive it. from NYT > Health ht… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment